Cargando…
Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
Objective: Sleep disorders are common in voltage-gated potassium channel complex antibody (VGKC-Ab) diseases. The aim was to investigate the sleep disturbances and polysomnography (PSG) characteristics in patients with VGKC-Ab-associated diseases. Methods: Twenty-seven patients with leucine-rich gli...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406672/ https://www.ncbi.nlm.nih.gov/pubmed/32849186 http://dx.doi.org/10.3389/fneur.2020.00696 |
_version_ | 1783567470912602112 |
---|---|
author | Lin, Nan Hao, Honglin Guan, Hongzhi Sun, Heyang Liu, Qing Lu, Qiang Jin, Liri Ren, Haitao Huang, Yan |
author_facet | Lin, Nan Hao, Honglin Guan, Hongzhi Sun, Heyang Liu, Qing Lu, Qiang Jin, Liri Ren, Haitao Huang, Yan |
author_sort | Lin, Nan |
collection | PubMed |
description | Objective: Sleep disorders are common in voltage-gated potassium channel complex antibody (VGKC-Ab) diseases. The aim was to investigate the sleep disturbances and polysomnography (PSG) characteristics in patients with VGKC-Ab-associated diseases. Methods: Twenty-seven patients with leucine-rich glioma-inactivated protein 1 antibody (LGI1-Ab) encephalitis, seven patients with contactin protein-like 2 antibody (Caspr2-Ab)-associated diseases, and 14 healthy controls with at least one PSG or actigraphy recording were recruited at Peking Union Medical College Hospital from January 2014 to July 2019. Results: Sleep disorders including insomnia, hypersomnia, rapid eye movement (REM) sleep behavior disorder (RBD), periodic limb movements in sleep (PLMS), agrypnia excitata, and obstructive sleep apnea syndrome were observed. Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). Of five patients with Caspr2-Ab-associated diseases, TST was found to be 329.5 (167.0–377.5 min), and sleep efficiency was found to be 61.7% (34.6–71.7%). The percentage for N3 and REM sleep was found to be 15.0% (0–34.6%) and 12.7% (0–22.2%), respectively. Both RBD and PLMS were observed more frequently in patients with LGI1-Ab encephalitis. We identified status dissociatus (SD) in five (23.8%) patients with LGI1-Ab encephalitis and two (40%) patients with Caspr2-Ab diseases. The former is more likely to have simple limb movements rather than complex movements, which mimic the contents of their dreams. Continuous insomnia was more common in patients with Caspr2-Ab diseases than patients with LGI1-Ab encephalitis. Patients reported clinical and PSG improvements following immunotherapy. Conclusion: Sleep disorders in patients with VGKC-Ab-associated diseases include decreased TST and poor sleep efficiency. Our studies provide evidence of SD in patients with LGI1-Ab encephalitis. |
format | Online Article Text |
id | pubmed-7406672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74066722020-08-25 Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases Lin, Nan Hao, Honglin Guan, Hongzhi Sun, Heyang Liu, Qing Lu, Qiang Jin, Liri Ren, Haitao Huang, Yan Front Neurol Neurology Objective: Sleep disorders are common in voltage-gated potassium channel complex antibody (VGKC-Ab) diseases. The aim was to investigate the sleep disturbances and polysomnography (PSG) characteristics in patients with VGKC-Ab-associated diseases. Methods: Twenty-seven patients with leucine-rich glioma-inactivated protein 1 antibody (LGI1-Ab) encephalitis, seven patients with contactin protein-like 2 antibody (Caspr2-Ab)-associated diseases, and 14 healthy controls with at least one PSG or actigraphy recording were recruited at Peking Union Medical College Hospital from January 2014 to July 2019. Results: Sleep disorders including insomnia, hypersomnia, rapid eye movement (REM) sleep behavior disorder (RBD), periodic limb movements in sleep (PLMS), agrypnia excitata, and obstructive sleep apnea syndrome were observed. Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). Of five patients with Caspr2-Ab-associated diseases, TST was found to be 329.5 (167.0–377.5 min), and sleep efficiency was found to be 61.7% (34.6–71.7%). The percentage for N3 and REM sleep was found to be 15.0% (0–34.6%) and 12.7% (0–22.2%), respectively. Both RBD and PLMS were observed more frequently in patients with LGI1-Ab encephalitis. We identified status dissociatus (SD) in five (23.8%) patients with LGI1-Ab encephalitis and two (40%) patients with Caspr2-Ab diseases. The former is more likely to have simple limb movements rather than complex movements, which mimic the contents of their dreams. Continuous insomnia was more common in patients with Caspr2-Ab diseases than patients with LGI1-Ab encephalitis. Patients reported clinical and PSG improvements following immunotherapy. Conclusion: Sleep disorders in patients with VGKC-Ab-associated diseases include decreased TST and poor sleep efficiency. Our studies provide evidence of SD in patients with LGI1-Ab encephalitis. Frontiers Media S.A. 2020-07-30 /pmc/articles/PMC7406672/ /pubmed/32849186 http://dx.doi.org/10.3389/fneur.2020.00696 Text en Copyright © 2020 Lin, Hao, Guan, Sun, Liu, Lu, Jin, Ren and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Lin, Nan Hao, Honglin Guan, Hongzhi Sun, Heyang Liu, Qing Lu, Qiang Jin, Liri Ren, Haitao Huang, Yan Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases |
title | Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases |
title_full | Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases |
title_fullStr | Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases |
title_full_unstemmed | Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases |
title_short | Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases |
title_sort | sleep disorders in leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated diseases |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406672/ https://www.ncbi.nlm.nih.gov/pubmed/32849186 http://dx.doi.org/10.3389/fneur.2020.00696 |
work_keys_str_mv | AT linnan sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases AT haohonglin sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases AT guanhongzhi sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases AT sunheyang sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases AT liuqing sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases AT luqiang sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases AT jinliri sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases AT renhaitao sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases AT huangyan sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases |